Lido Advisors LLC bought a new stake in shares of Haleon plc (NYSE:HLN – Get Rating) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 11,546 shares of the company’s stock, valued at approximately $70,000.
Several other large investors have also modified their holdings of the business. Marathon Capital Management purchased a new position in shares of Haleon during the third quarter valued at approximately $78,000. Marshall Wace LLP bought a new stake in shares of Haleon during the third quarter valued at approximately $352,000. Evergreen Capital Management LLC bought a new stake in shares of Haleon during the third quarter valued at approximately $121,000. Engineers Gate Manager LP bought a new stake in shares of Haleon during the third quarter valued at approximately $93,000. Finally, First Manhattan Co. bought a new stake in shares of Haleon during the third quarter valued at approximately $105,000. Hedge funds and other institutional investors own 6.67% of the company’s stock.
Analysts Set New Price Targets
Several analysts have recently weighed in on HLN shares. Barclays lifted their price target on shares of Haleon from GBX 360 ($4.33) to GBX 364 ($4.38) in a research note on Tuesday, January 31st. Investec started coverage on shares of Haleon in a research note on Thursday, February 23rd. They set a “sell” rating for the company. Finally, Morgan Stanley raised shares of Haleon from an “equal weight” rating to an “overweight” rating in a research note on Friday, January 6th. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $364.00.
Haleon Price Performance
Haleon Dividend Announcement
The firm also recently disclosed a — dividend, which will be paid on Thursday, April 27th. Investors of record on Friday, March 17th will be paid a $0.0577 dividend. This represents a yield of 0.7%. The ex-dividend date of this dividend is Thursday, March 16th.
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements.
- Get a free copy of the StockNews.com research report on Haleon (HLN)
- What the SVB Financial Collapse Means for U.S. Banks
- MarketBeat Week in Review – 3/6 – 3/10
- 2 Offshore Drilling Stocks Set to Extract Big Profits
- Three Staples Stocks With Double-Digit Upside Ahead
- Can Investors Trust Consumers to Lift American Outdoor Brands?
Want to see what other hedge funds are holding HLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Haleon plc (NYSE:HLN – Get Rating).
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.